Botulinum neurotoxins: perspective on their existence and as polyproteins harboring viral proteases.
暂无分享,去创建一个
[1] T. Galli,et al. Tetanus toxin-mediated cleavage of cellubrevin inhibits proton secretion in the male reproductive tract. , 2000, American journal of physiology. Renal physiology.
[2] T. Galli,et al. The Tetanus Neurotoxin‐Sensitive and Insensitive Routes to and from the Plasma Membrane: Fast and Slow Pathways? , 2005, Traffic.
[3] T. Meyer,et al. Immunoglobulin A1 Protease, an Exoenzyme of Pathogenic Neisseriae, Is a Potent Inducer of Proinflammatory Cytokines , 1999, The Journal of experimental medicine.
[4] East,et al. Phylogeny and taxonomy of the food‐borne pathogen Clostridium botulinum and its neurotoxins , 1998, Journal of applied microbiology.
[5] Andrew A. Peden,et al. A genomic perspective on membrane compartment organization , 2001, Nature.
[6] Leonard A. Smith,et al. Autocatalytically fragmented light chain of botulinum a neurotoxin is enzymatically active. , 2003, Biochemistry.
[7] T. Südhof,et al. Cleavage of members of the synaptobrevin/VAMP family by types D and F botulinal neurotoxins and tetanus toxin. , 1994, The Journal of biological chemistry.
[8] H. Sugiyama,et al. Evidence that subunits of type A botulinum toxin need not be linked by disulfide. , 1988, Toxicon : official journal of the International Society on Toxinology.
[9] M. Eklund,et al. CHAPTER 2 – Bacteriophages and Plasmids in Clostridium botulinum and Clostridium tetani and Their Relationship to Production of Toxins , 1989 .
[10] R. Millonig. ISOLATION OF AN AMINOPEPTIDASE FROM TYPE B CLOSTRIDIUM BOTULINUM , 1956, Journal of bacteriology.
[11] Rainer Merkl,et al. The genome sequence of Clostridium tetani, the causative agent of tetanus disease , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[12] R. Stevens,et al. Sequence homology and structural analysis of the clostridial neurotoxins. , 1999, Journal of molecular biology.
[13] S. Gottesman,et al. Regulation by proteolysis: energy-dependent proteases and their targets , 1992, Microbiological reviews.
[14] N. Minton. Molecular genetics of clostridial neurotoxins. , 1995, Current topics in microbiology and immunology.
[15] A. B. Maksymowych,et al. The Role of Exoproteases in Governing Intraneuronal Metabolism of Botulinum Toxin , 2005, The protein journal.
[16] T. Frey,et al. Characterization of the Zinc Binding Activity of the Rubella Virus Nonstructural Protease , 2000, Journal of Virology.
[17] T. Galli,et al. [Tetanus neurotoxin-mediated cleavage of cellubrevin impairs epithelial cell migration and integrin-dependent cell adhesion]. , 2005, Medecine sciences : M/S.
[18] 平田 文範,et al. Clostridium botulinum , 2022, CABI Compendium.
[19] Haroun Shah,et al. Gastrointestinal microflora studies in late-onset autism. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[20] G. Schiavo,et al. Neurotoxins affecting neuroexocytosis. , 2000, Physiological reviews.
[21] J. Peng,et al. A baculovirus enhancin alters the permeability of a mucosal midgut peritrophic matrix from lepidopteran larvae. , 1999, Journal of insect physiology.
[22] H. Neurath. Proteolytic enzymes, past and present. , 1985, Federation proceedings.
[23] S. Swaminathan,et al. Structural analysis of the catalytic and binding sites of Clostridium botulinum neurotoxin B , 2000, Nature Structural Biology.
[24] H. Neurath,et al. Evolution of proteolytic enzymes. , 1984, Science.
[25] N. Minton,et al. The Genetic Basis of Toxin Production in Clostridium botulinum and Clostridium tetani , 1997 .
[26] R. Stevens,et al. Crystal structure of botulinum neurotoxin type A and implications for toxicity , 1998, Nature Structural Biology.
[27] M. Sheng,et al. Neurobiology: Synapses unplugged , 2003, Nature.
[28] E R Bolte,et al. Autism and Clostridium tetani. , 1998, Medical hypotheses.
[29] Y. Humeau,et al. How botulinum and tetanus neurotoxins block neurotransmitter release. , 2000, Biochimie.
[30] D. Burns. Type IV Secretion Systems , 2003 .
[31] D. Caugant,et al. Molecular polymorphism and epidemiology of Neisseria meningitidis immunoglobulin A1 proteases. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[32] K. Ishii,et al. Processing and Functions of Hepatitis C Virus Proteins , 1999, Intervirology.
[33] Y. Kamata,et al. Lectins from Triticum vulgaris and Limax flavus are universal antagonists of botulinum neurotoxin and tetanus toxin. , 1991, The Journal of pharmacology and experimental therapeutics.
[34] E. Wimmer,et al. Viral proteinases. , 1988, Annual review of biochemistry.
[35] L. Simpson. Molecular pharmacology of botulinum toxin and tetanus toxin. , 1986, Annual review of pharmacology and toxicology.
[36] T. Südhof,et al. α-Neurexins couple Ca2+ channels to synaptic vesicle exocytosis , 2003, Nature.
[37] Miroslav Radman,et al. Fidelity and infidelity , 2001, Nature.
[38] Leonard A. Smith,et al. Enzymatic Autocatalysis of Botulinum A Neurotoxin Light Chain , 2001, Journal of protein chemistry.
[39] H. Pelham. SNAREs and the specificity of membrane fusion. , 2001, Trends in cell biology.
[40] J. Rothman,et al. Functional architecture of an intracellular membrane t-SNARE , 2000, Nature.
[41] N. Sharon. Bacterial lectins, cell‐cell recognition and infectious disease , 1987, FEBS letters.
[42] B. Semler,et al. Expression of virus-encoded proteinases: functional and structural similarities with cellular enzymes. , 1993, Microbiological reviews.
[43] Eric A. Johnson,et al. Clostridium botulinum and its neurotoxins: a metabolic and cellular perspective. , 2001, Toxicon : official journal of the International Society on Toxinology.
[44] Eric A. Johnson. Extrachromosomal Virulence Determinants in the Clostridia , 1997 .
[45] W. Tepp,et al. Botulinum neurotoxin types B and E: purification, limited proteolysis by endoproteinase Glu-C and pepsin, and comparison of their identified cleaved sites relative to the three-dimensional structure of type A neurotoxin. , 2001, Toxicon : official journal of the International Society on Toxinology.
[46] R. R. Granados,et al. Enhancin, the granulosis virus protein that facilitates nucleopolyhedrovirus (NPV) infections, is a metalloprotease. , 1996, Journal of invertebrate pathology.
[47] W. Betz,et al. Neurobiology: All change at the synapse , 2003, Nature.
[48] C. Quinn,et al. Expression and purification of catalytically active, non-toxic endopeptidase derivatives of Clostridium botulinum toxin type A. , 2002, Protein expression and purification.
[49] Erich Kombrink,et al. SNARE-protein-mediated disease resistance at the plant cell wall , 2003, Nature.
[50] P. De Camilli,et al. Tetanus toxin-mediated cleavage of cellubrevin impairs exocytosis of transferrin receptor-containing vesicles in CHO cells , 1994, The Journal of cell biology.
[51] W. Tepp,et al. Botulinum Neurotoxin Types A, B, and E: Fragmentations by Autoproteolysis and Other Mechanisms Including by O-Phenanthroline–Dithiothreitol, and Association of the Dinucleotides NAD+/NADH with the Heavy Chain of the Three Neurotoxins , 2005, The protein journal.
[52] A. Tomasselli,et al. A cumulative specificity model for proteases from human immunodeficiency virus types 1 and 2, inferred from statistical analysis of an extended substrate data base. , 1991, The Journal of biological chemistry.
[53] G. Schiavo,et al. Structure and function of tetanus and botulinum neurotoxins , 1995, Quarterly Reviews of Biophysics.
[54] H. Pelham,et al. A New Yeast Endosomal SNARE Related to Mammalian Syntaxin 8 , 2002, Traffic.